Surgical care quality and oncologic outcome after D2 gastrectomy for gastric cancer

doi:10.3748/wjg.v21.i47.13294

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 21, Issue 47

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (8713)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-3) series.

Item

Count

PDF

618

WORD

379

HTML

4437

Figures (1-1)

228

Tables (1-3)

217

Sum=5879

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1166

Download

1668

Sum=2834

Dec 21, 2015 (publication date) through Nov 23, 2024

Times Cited of This Article

Times Cited (8)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Gastroenterol. Dec 21, 2015; 21(47): 13294-13301
Published online Dec 21, 2015. doi: 10.3748/wjg.v21.i47.13294

Table 1 Baseline characteristics (n = 109)

Characteristic	n (%)
Male gender	51 (46.8)
Body mass index (kg/m²), mean (SD)	25.6 (4.9)
ASA score III-IV	67 (61.5)
Tumor site
Upper	21 (19.3)
Middle	43 (39.4)
Lower	38 (34.9)
All levels	7 (6.4)
UICC tumor stage
I	27 (24.8)
II	31 (28.4)
III	41 (37.6)
IV	10 (9.2)
Tumor type
Intestinal	50 (45.9)
Diffuse	56 (51.4)
Mixed	3 (2.8)
Lymph node invasion
No	45 (41.2)
Yes	64 (58.7)
Type of surgery
Total gastrectomy	103 (94.5)
Subtotal gastric resection	6 (5.5)
D2-lymph node dissection	109 (100)
Splenectomy	48 (44.0)
Cholecystectomy	19 (17.4)
Additional organ resection due to cancer invasion	10 (9.2)
Radicality
R0	104 (95.4)
Neoadjuvant/adjuvant treatment
No	69 (63.3)
Neoadjuvant chemoradiotherapy	2 (1.8)
Adjuvant chemotherapy	26 (23.9)
Adjuvant chemoradiotherapy	12 (11.0)

ASA: American Society of Anesthesiologists; UICC: Union for International Cancer Control.

Citation: Mrena J, Mattila A, Böhm J, Jantunen I, Kellokumpu I. Surgical care quality and oncologic outcome after D2 gastrectomy for gastric cancer. World J Gastroenterol 2015; 21(47): 13294-13301
URL: https://www.wjgnet.com/1007-9327/full/v21/i47/13294.htm
DOI: https://dx.doi.org/10.3748/wjg.v21.i47.13294